news[Former Asklep] ASKLEP & Harrison Clinical Research Group sign Strategic Partnership Agreement and Joint Operating Plan

*Articles from the former Asklep

ASKLEP Inc., a Japan based CRO providing clinical research services and the Harrison Clinical Research Group, a European CRO headquartered in Munich, Germany, today announced the signing of a Strategic Partnership Agreement further solidifying the partnership between the two companies. The agreement means the two companies can offer their wide range of clinical research services to pharmaceutical, biotechnology and device companies in a much wider geographic area, ASKLEP with coverage in Japan and HCR throughout Western and Eastern Europe.

Takenori Ogawa, President of ASKLEP commented “ASKLEP and Harrison have collaborated for the past two years and this partnership agreement is a further step we have taken to accelerate service capabilities beyond Japan. Partnering with the Harrison Clinical Group, with their 20 years experience, excellent reputation, and know-how in clinical research gives us a footprint in the global trial arena and allows our clients smooth access to Harrison’s vast clinical resources.”

Dr. Francisco Harrison, Chairman of Harrison Clinical Research Group said, “Harrison Clinical Research Group is very pleased with this announcement and the development of such partnership in Japan. We are not only honoured by the possibility to develop global business together with Asklep for the Japanese Pharmaceutical and Biotechnology Industries, but also this opens new possibilities of collaboration in other territories in Asia and Europe. The experience of working with Asklep during these years have shown that there are several common values shared by both companies based on client oriented services, quality and professionalism, offering our clients the most advanced solutions to their Clinical Research needs and doing that in an international frame with many years of experience in both companies. We are looking forward to strengthen our collaboration with Asklep in Japan and beyond in the years to come”

About ASKLEP

Asklep, Inc., (http://www.asklep.co.jp) founded in 1992, in Tokyo, Japan, provides clinical research services in monitoring, data management, biostatistics, regulatory & consulting, CRA training, etc. ASKLEP is an INTAGE Group Company. INTAGE, INC., (http://www.intage.co.jp) is the largest marketing research company in Japan and the eleventh largest globally. It has one of the most comprehensive healthcare solution services in the industry

About Harrison Clinical Research Group

Harrison Clinical Research Group (www.harrisonclinical.com), is a Munich, Germany based CRO with 11 offices throughout Europe, and a state-of-the-art Phase I facility in Munich. Harrison offers the full-range of services required for the clinical development and registration of new pharmaceutical products and medical devices, from single studies to complete development programs. The international project management and monitoring teams perform Phase I – IV studies either locally or globally, as required. HCR was established in 1987 and is ISO9001:2000 compliant.

Media Contacts

Inquiry
INTAGE Healthcare Inc.

SHARE

facebooktwitter